(Reuters) – A highly anticipated new immunotherapy from Merck Co Inc proved effective in patients with advanced melanoma as well as some with lung cancer or head and neck cancer, according to early-stage studies presented on Monday.
Merck filed in January for U.S. Food and Drug…
Merck immune system-booster effective in skin, lung cancer
No comments:
Post a Comment